Purigen Biosystems develops an isotachophoresis chip for nucleic acid preparation. Founded by Amy Hiddessen, Juan Santiago, and Klint Rose in 2012, Purigen Biosystems is backed by investors that include 5AM Ventures, Agilent Technologies, Cota Capital, Roche Venture Fund, and StartX (Stanford-StartX Fund) and is headquartered in Pleasanton.